- Home
- CDXS vs DHF Comparison
CDXS vs DHF Comparison
Compare CDXS & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- DHF
- Stock Information
- Founded
- CDXS 2002
- DHF 1998
- Country
- CDXS United States
- DHF United States
- Employees
- CDXS N/A
- DHF N/A
- Industry
- CDXS Major Chemicals
- DHF Finance Companies
- Sector
- CDXS Industrials
- DHF Finance
- Exchange
- CDXS Nasdaq
- DHF Nasdaq
- Market Cap
- CDXS 216.6M
- DHF 189.3M
- IPO Year
- CDXS 2010
- DHF N/A
- Fundamental
- Price
- CDXS $2.65
- DHF $2.54
- Analyst Decision
- CDXS Buy
- DHF
- Analyst Count
- CDXS 2
- DHF 0
- Target Price
- CDXS $11.00
- DHF N/A
- AVG Volume (30 Days)
- CDXS 542.5K
- DHF 451.1K
- Earning Date
- CDXS 10-30-2025
- DHF 01-01-0001
- Dividend Yield
- CDXS N/A
- DHF 7.65%
- EPS Growth
- CDXS N/A
- DHF N/A
- EPS
- CDXS N/A
- DHF N/A
- Revenue
- CDXS $57,164,000.00
- DHF N/A
- Revenue This Year
- CDXS $12.88
- DHF N/A
- Revenue Next Year
- CDXS $21.64
- DHF N/A
- P/E Ratio
- CDXS N/A
- DHF N/A
- Revenue Growth
- CDXS N/A
- DHF N/A
- 52 Week Low
- CDXS $1.90
- DHF $2.06
- 52 Week High
- CDXS $6.08
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- CDXS 55.26
- DHF 34.79
- Support Level
- CDXS $2.46
- DHF $2.56
- Resistance Level
- CDXS $2.76
- DHF $2.58
- Average True Range (ATR)
- CDXS 0.16
- DHF 0.02
- MACD
- CDXS 0.02
- DHF -0.00
- Stochastic Oscillator
- CDXS 50.97
- DHF 12.64
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. The fund invests predominantly in fixed-income securities of below-investment-grade credit quality.